Soft Tissue Neoplasm - Rhabdomyosarcoma
NCT00075582
Clinical Trial Information
Trial Number: NCT00075582 (ClinicalTrials.gov)
Disease Type:
- Soft Tissue Neoplasm - Rhabdomyosarcoma
Trial Title:
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients With Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma
Study ID:
ARST0331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00075582-D1 | NCT00075582-D1 is the only dataset for this manuscript (PMID 28211936). There is one row for each patient enrolled. The dataset contains the baseline patient characteristics, radiation received, delayed surgery received, adverse events and survival outcomes for patients on ARST0331 as reported in the manuscript. |
NCT00354835
Clinical Trial Information
Trial Number: NCT00354835 (ClinicalTrials.gov)
Disease Type:
- Soft Tissue Neoplasm - Rhabdomyosarcoma
Trial Title:
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS)
Study ID:
ARST0531
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00354835-D3 | There are three datasets associated with PubMed ID 30091945: NCT00354835-D1, NCT00354835-D2, and NCT00354835-D3. Dataset NCT00354835-D3 is required for comparing the results of ARST0531 to the previous D9803 study. This dataset includes variables describing OS, EFS, histology, group, and stage. |
| NCT00354835-D2 | There are three datasets associated with PubMed ID 30091945: NCT00354835-D1, NCT00354835-D2, and NCT00354835-D3. Dataset NCT00354835-D2 is required for recreating which patients were deemed ineligible and the reason. |
| NCT00354835-D1 | There are three datasets associated with PubMed ID 30091945: NCT00354835-D1, NCT00354835-D2, and NCT00354835-D3. Dataset NCT00354835-D1 is required for re-creating the main results of the manuscript. The data contains information including histology, group, adverse events, stage, EFS and OS, and demographics. |
NCT00354744
Clinical Trial Information
Trial Number: NCT00354744 (ClinicalTrials.gov)
Disease Type:
- Soft Tissue Neoplasm - Rhabdomyosarcoma
Trial Title:
Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma
Study ID:
ARST0431
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00354744-D2 | NCT00354744-D2 This dataset contains incidence of adverse events as reported in the manuscript. |
| NCT00354744-D1 | NCT00354744-D1 There is one row for each patient enrolled. The dataset contains the patient characteristics, Oberlin risk groups, reporting period duration, radiation by reporting period, and survival outcomes for patients on ARST0431 as reported in the manuscript. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®